ATE116367T1 - Für antitumor-polypeptide kodierende dns, die polypeptide und diese polypeptide enthaltenden antitumor-wirkstoffe. - Google Patents
Für antitumor-polypeptide kodierende dns, die polypeptide und diese polypeptide enthaltenden antitumor-wirkstoffe.Info
- Publication number
- ATE116367T1 ATE116367T1 AT87400261T AT87400261T ATE116367T1 AT E116367 T1 ATE116367 T1 AT E116367T1 AT 87400261 T AT87400261 T AT 87400261T AT 87400261 T AT87400261 T AT 87400261T AT E116367 T1 ATE116367 T1 AT E116367T1
- Authority
- AT
- Austria
- Prior art keywords
- leu
- ala
- gln
- glu
- gly
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/525—Tumour necrosis factor [TNF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2130286 | 1986-02-04 | ||
JP2422086 | 1986-02-07 | ||
JP61169522A JP2544114B2 (ja) | 1985-11-15 | 1986-07-17 | 新規dna及びそれを含有する新規プラスミド |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE116367T1 true ATE116367T1 (de) | 1995-01-15 |
Family
ID=27283374
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT87400261T ATE116367T1 (de) | 1986-02-04 | 1987-02-04 | Für antitumor-polypeptide kodierende dns, die polypeptide und diese polypeptide enthaltenden antitumor-wirkstoffe. |
Country Status (5)
Country | Link |
---|---|
US (1) | US5081021A (de) |
EP (1) | EP0247906B1 (de) |
AT (1) | ATE116367T1 (de) |
CA (1) | CA1340998C (de) |
DE (1) | DE3750915T2 (de) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1988006625A2 (en) * | 1987-02-26 | 1988-09-07 | Cetus Corporation | Arginine-depleted human tumor necrosis factor |
US6569679B1 (en) | 1988-03-21 | 2003-05-27 | Chiron Corporation | Producer cell that generates adenoviral vectors encoding a cytokine and a conditionally lethal gene |
US5716826A (en) * | 1988-03-21 | 1998-02-10 | Chiron Viagene, Inc. | Recombinant retroviruses |
US6133029A (en) * | 1988-03-21 | 2000-10-17 | Chiron Corporation | Replication defective viral vectors for infecting human cells |
US6241982B1 (en) | 1988-03-21 | 2001-06-05 | Chiron Corporation | Method for treating brain cancer with a conditionally lethal gene |
JP2828988B2 (ja) * | 1988-04-03 | 1998-11-25 | 源一郎 杣 | 新規dnaとその生産方法、それを有する新規プラスミド、新規ポリペプチドとその生産方法、及び該ポリペプチドからなる新規抗腫瘍剤 |
DE3841755A1 (de) * | 1988-12-12 | 1990-06-13 | Basf Ag | Neue tnf-peptide |
DE3841763A1 (de) * | 1988-12-12 | 1990-06-13 | Basf Ag | Neue tnf-peptide |
DE3843534A1 (de) * | 1988-12-23 | 1990-07-12 | Basf Ag | Neue tnf-polypeptide |
ATE199398T1 (de) * | 1989-10-24 | 2001-03-15 | Chiron Corp | Sekretion vom mit gamma-interferon signalpeptid gebundenen humänen protein |
DK53291D0 (da) * | 1991-03-25 | 1991-03-25 | Carlbiotech Ltd As | Smaa peptider og peptidrelaterede stoffer samt farmaceutiske praeparater indeholdende saadanne forbindelser |
CA2158936C (en) | 1993-11-18 | 2012-02-21 | Jack R. Barber | Compositions and methods for utilizing conditionally lethal genes |
US5888814A (en) * | 1994-06-06 | 1999-03-30 | Chiron Corporation | Recombinant host cells encoding TNF proteins |
CN1049663C (zh) * | 1994-09-01 | 2000-02-23 | 中国科学院上海生物工程研究中心 | 突变的人肿瘤坏死因子 |
US20070172449A1 (en) * | 2000-03-02 | 2007-07-26 | Xencor, Inc. | TNF-alpha VARIANT FORMULATIONS FOR THE TREATMENT OF TNF-alpha RELATED DISORDERS |
US7687461B2 (en) * | 2000-03-02 | 2010-03-30 | Xencor, Inc. | Treatment of TNF-α related disorders with TNF-α variant proteins |
US7056695B2 (en) | 2000-03-02 | 2006-06-06 | Xencor | TNF-α variants |
US7662367B2 (en) * | 2000-03-02 | 2010-02-16 | Xencor, Inc. | Pharmaceutical compositions for the treatment of TNF-α related disorders |
US7101974B2 (en) | 2000-03-02 | 2006-09-05 | Xencor | TNF-αvariants |
US7244823B2 (en) * | 2000-03-02 | 2007-07-17 | Xencor | TNF-alpha variants proteins for the treatment of TNF-alpha related disorders |
US7446174B2 (en) | 2001-03-02 | 2008-11-04 | Xencor, Inc. | Protein based TNF-α variants for the treatment of TNF-α related disorders |
WO2004050683A2 (en) * | 2002-12-02 | 2004-06-17 | Abgenix, Inc. | Antibodies directed to tumor necrosis factor and uses thereof |
US7964470B2 (en) * | 2006-03-01 | 2011-06-21 | Taiwan Semiconductor Manufacturing Company, Ltd. | Flexible processing method for metal-insulator-metal capacitor formation |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4769326A (en) * | 1980-02-29 | 1988-09-06 | The Regents Of The University Of California | Expression linkers |
US4532207A (en) * | 1982-03-19 | 1985-07-30 | G. D. Searle & Co. | Process for the preparation of polypeptides utilizing a charged amino acid polymer and exopeptidase |
EP0155549B1 (de) * | 1984-03-06 | 1991-03-20 | Dainippon Pharmaceutical Co., Ltd. | DNS den menschlichen Tumornekrosisfaktor kodierend und das menschliche Tumornekronisfaktor-Polypeptid |
GR851626B (de) * | 1984-07-05 | 1985-11-26 | Genentech Inc | |
US4677063A (en) * | 1985-05-02 | 1987-06-30 | Cetus Corporation | Human tumor necrosis factor |
US4959314A (en) * | 1984-11-09 | 1990-09-25 | Cetus Corporation | Cysteine-depleted muteins of biologically active proteins |
US4677069A (en) * | 1984-12-18 | 1987-06-30 | Cornell Research Foundation, Inc. | Clam derived proteinases |
DE3585690D1 (de) * | 1984-12-21 | 1992-04-23 | Biogen Inc | Reinigung, herstellung und verwendung von tumor-nekrosisfaktoren. |
EP0205038A1 (de) * | 1985-05-29 | 1986-12-17 | Suntory Limited | Polypeptid, Verfahren zu dessen Herstellung, Mikroorganismus und pharmazeutische Verwendung |
JPS6248634A (ja) * | 1985-07-23 | 1987-03-03 | Mochida Pharmaceut Co Ltd | 新規アミノ酸組成物、その製造方法及び該アミノ酸組成物を含有する医療組成物 |
JPH064675B2 (ja) * | 1985-07-29 | 1994-01-19 | 伝一 水野 | 抗腫瘍性ポリペプチド |
JPH0698004B2 (ja) * | 1985-09-30 | 1994-12-07 | サントリー株式会社 | Tnf発現用新規プラスミド |
JPS6293233A (ja) * | 1985-10-18 | 1987-04-28 | Denichi Mizuno | Dna及びそれを有する微生物を用いる抗腫瘍性ポリペプチドの製造法 |
DE3750056T2 (de) * | 1986-06-20 | 1995-04-06 | Dainippon Pharmaceutical Co | Polypeptid-Mutanten des menschlichen TNF und für diese Mutanten codierende DNS. |
-
1987
- 1987-02-04 EP EP87400261A patent/EP0247906B1/de not_active Expired - Lifetime
- 1987-02-04 CA CA000528947A patent/CA1340998C/en not_active Expired - Fee Related
- 1987-02-04 US US07/010,692 patent/US5081021A/en not_active Expired - Fee Related
- 1987-02-04 DE DE3750915T patent/DE3750915T2/de not_active Expired - Fee Related
- 1987-02-04 AT AT87400261T patent/ATE116367T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0247906A2 (de) | 1987-12-02 |
DE3750915T2 (de) | 1995-08-24 |
EP0247906A3 (en) | 1988-12-07 |
CA1340998C (en) | 2000-05-23 |
DE3750915D1 (de) | 1995-02-09 |
US5081021A (en) | 1992-01-14 |
EP0247906B1 (de) | 1994-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE116367T1 (de) | Für antitumor-polypeptide kodierende dns, die polypeptide und diese polypeptide enthaltenden antitumor-wirkstoffe. | |
DE3687763D1 (de) | Oxidationsbestaendige il-2-muteine und ihre herstellung, diese muteine enthaltende zusammensetzungen, solche muteine kodierende dns-sequenzen und expressionsvektoren und korrespondierende transformierte wirtzellen. | |
HUT46061A (en) | Dna sequences encoding hirudin-like protein and process for producing such proteins | |
DK0931148T3 (da) | Fibroblast-vækstfaktorhomologer | |
TW327194B (en) | Novel amyloid precursor proteins and methods of using same | |
EP0182372A3 (de) | Faktor-VIII-gerinnende Polypeptide | |
IL75963A (en) | Omega interferon polypeptides of type 1,n-glycosylated derivatives thereof with omega interferon activity,polynucleotide sequences encoding the omega interferon polypeptides,methods for the preparation of the polypeptides and pharmaceutical compositions containing them | |
ATE175210T1 (de) | Ein neues, biologisch aktives vom huhn stammendes peptid (huhn-cnp) | |
NO177570C (no) | Fremgangsmåte ved fremstilling av peptider med fibronektinbindende egenskaper, mikroorganisme og DNA-sekvens som koder for peptider med fibronektinbindende egenskaper | |
IL80562A0 (en) | Recombinant human lysozyme,its preparation by recombinant dna technology and pharmaceutical compositions containing it | |
DE3683910D1 (de) | Oxidationsresistente muteine von beta-interferon, deren herstellung und diese muteine enthaltende praeparate. | |
ATE75420T1 (de) | Verfahren zur herstellung von ammoniak und zur hydrierung von olefinen. | |
NZ303588A (en) | Mpl ligand analogs having one or more changed glycosylation sites uses for these ligand analogs and dna sequences encoding them | |
ATE94588T1 (de) | Verfahren zur herstellung und reinigung von alpha-interferon. | |
NZ238331A (en) | Peptide with peptidylhydroxyglycine n-c lyase activity, dna encoding it and its preparation and its use | |
SE8502430D0 (sv) | A cdna molecule coding for the expression of an interferon alfa type polypeptide, a bacterial or cellular host transformed with such molecule and a polypeptide showing interferon activity prepared by such host | |
DK595187A (da) | Minactivin og fremgangsmaade til fremstilling deraf | |
EP0367641A3 (en) | Lymphokines, dna sequences encoding these lymphokines and pharmaceutical compositions containing these lymphokines | |
ATE102997T1 (de) | Thymosin und tnf-kodierende dna. | |
DE69432724D1 (de) | HST-2 Mutein, dafür kodierende DNS und Herstellung | |
EP0233578A3 (de) | Polypeptid mit Interleukin-2-Aktivitäten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |